OTCM
BRSF
Market cap931kUSD
Jul 16, Last price
0.75USD
1D
0.00%
IPO
-74.14%
Name
Brain Scientific Inc
Chart & Performance
Profile
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. The company also develops motor platforms; an ultra-precise micro dosing pump; and motion products. The company offers NeuroCap, a disposable and soft layered cap with an integrated electrode circuit that is designed to address existing problems of conventional EEG systems; and NeuroEEG, a clinical-grade device for prescription use to acquire, record, transmit, and display electrical brain activity for patients of all ages, as well as NeuroNet Cloud, a database where brain data can be stored and analyzed. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||
Revenues | 215 -19.26% | |||||||
Cost of revenue | 9,823 | |||||||
Unusual Expense (Income) | ||||||||
NOPBT | (9,608) | |||||||
NOPBT Margin | ||||||||
Operating Taxes | (863) | |||||||
Tax Rate | ||||||||
NOPAT | (8,746) | |||||||
Net income | (11,481) 17.49% | |||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
Debt | ||||||||
Debt current | 2,856 | |||||||
Long-term debt | 98 | |||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | 2,207 | |||||||
Cash flow | ||||||||
Cash from operating activities | (5,935) | |||||||
CAPEX | (33) | |||||||
Cash from investing activities | (33) | |||||||
Cash from financing activities | 5,931 | |||||||
FCF | (7,856) | |||||||
Balance | ||||||||
Cash | 748 | |||||||
Long term investments | ||||||||
Excess cash | 737 | |||||||
Stockholders' equity | (34,626) | |||||||
Invested Capital | 41,806 | |||||||
ROIC | ||||||||
ROCE | ||||||||
EV | ||||||||
Common stock shares outstanding | 953 | |||||||
Price | 0.10 -61.57% | |||||||
Market cap | 95 1.50% | |||||||
EV | 2,302 | |||||||
EBITDA | (8,784) | |||||||
EV/EBITDA | ||||||||
Interest | 3,605 | |||||||
Interest/NOPBT |